Your browser doesn't support javascript.
loading
Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis.
Avgerinos, Ioannis; Michailidis, Theodoros; Liakos, Aris; Karagiannis, Thomas; Matthews, David R; Tsapas, Apostolos; Bekiari, Eleni.
Afiliación
  • Avgerinos I; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Michailidis T; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Liakos A; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Karagiannis T; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Matthews DR; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Tsapas A; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Bekiari E; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Diabetes Obes Metab ; 22(3): 335-345, 2020 03.
Article en En | MEDLINE | ID: mdl-31637820

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Péptidos Similares al Glucagón Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Grecia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Péptidos Similares al Glucagón Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Grecia